Home/Filings/4/0001578563-24-000441
4//SEC Filing

Almenoff June Sherie 4

Accession 0001578563-24-000441

CIK 0001534120other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:21 PM ET

Size

7.1 KB

Accession

0001578563-24-000441

Insider Transaction Report

Form 4
Period: 2024-11-12
Transactions
  • Purchase

    Common Stock

    2024-11-12$12.50/sh+500$6,250500 total(indirect: By LLC)
  • Purchase

    Common Stock

    2024-11-13$13.00/sh+500$6,5001,000 total(indirect: By LLC)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001492647

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:21 PM ET
Size
7.1 KB